down arrow

CStone Pharmaceuticals Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG2588M1006
HKD
6.12
0.37 (6.43%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Consun Pharmaceutical Group Ltd.
Tong Ren Tang Technologies Co., Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Asymchem Laboratories (Tianjin) Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Ocumension Therapeutics
3D Medicines, Inc.
Shanghai Junshi Biosciences Co., Ltd.
CARsgen Therapeutics Holdings Ltd.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
CStone Pharmaceuticals Co. Ltd.
Why is CStone Pharmaceuticals Co. Ltd. ?
1
Weak Long Term Fundamental Strength with a 12.64% CAGR growth in Operating Profits over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -359.62
2
Negative results in Jun 25
  • ROCE(HY) Lowest at -95.84%
  • RAW MATERIAL COST(Y) Grown by 526.13% (YoY)
  • CASH AND EQV(HY) Lowest at HKD 715.12 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 152.89%, its profits have fallen by -146.5%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CStone Pharmaceuticals Co. Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
CStone Pharmaceuticals Co. Ltd.
133.59%
4.74
89.27%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
194.13%
EBIT Growth (5y)
12.64%
EBIT to Interest (avg)
-359.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.89
Sales to Capital Employed (avg)
0.47
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
40.04
EV to EBIT
-33.69
EV to EBITDA
-38.66
EV to Capital Employed
240.18
EV to Sales
61.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-713.01%
ROE (Latest)
-113.92%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
OPERATING CASH FLOW(Y)

Highest at HKD -629.21 MM

-19What is not working for the Company
ROCE(HY)

Lowest at -95.84%

RAW MATERIAL COST(Y)

Grown by 526.13% (YoY

CASH AND EQV(HY)

Lowest at HKD 715.12 MM

DEBT-EQUITY RATIO (HY)

Highest at -82.97 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 1.68%

NET SALES(Q)

Lowest at HKD 53.12 MM

OPERATING PROFIT MARGIN(Q)

Lowest at -515.79 %

PRE-TAX PROFIT(Q)

Lowest at HKD -287.55 MM

NET PROFIT(Q)

Lowest at HKD -287.55 MM

EPS(Q)

Lowest at HKD -0.22

Here's what is working for CStone Pharmaceuticals Co. Ltd.
Operating Cash Flow
Highest at HKD -629.21 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Here's what is not working for CStone Pharmaceuticals Co. Ltd.
Pre-Tax Profit
At HKD -287.55 MM has Fallen at -2,619.58%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (HKD MM)

Net Profit
At HKD -287.55 MM has Fallen at -2,619.58%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (HKD MM)

Net Sales
At HKD 53.12 MM has Fallen at -80.71%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (HKD MM)

Net Sales
Lowest at HKD 53.12 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (HKD MM)

Operating Profit Margin
Lowest at -515.79 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at HKD -287.55 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit
Lowest at HKD -287.55 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (HKD MM)

EPS
Lowest at HKD -0.22
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (HKD)

Cash and Eqv
Lowest at HKD 715.12 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at -82.97 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio
Lowest at 1.68%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 526.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."